Hepatitis C in Veterans
December 3, 2014
11:30 AM
Russell Senate Office Building
SR-418
If you are having trouble viewing this hearing, please try the following steps:
- Clear your browser's cache - Guide to clearing browser cache
- Close and re-open your browser
- If the above two steps do not help, please try another browser. Google Chrome and Microsoft Edge have the highest level of compatibility with our player.
Agenda
PANEL I
Michael Valentino, R. Ph., MHSA, Chief Consultant, Pharmacy Benefits Management Services
Accompanied By:
David Ross, MD, PhD, MBI, Director, HIV, Hepatitis C, and Public Health Pathogens Programs, Office of Public Health/Clinical Public Health, Veterans Health Administration, Department of Veterans Affairs
-
PANEL II
John C. Martin, PhD, Chairman and Chief Executive Officer, Gilead Sciences, Inc. (Invited)
John Rother, President and Chief Executive Officer, National Coalition on Health Care
Robert Weissman, Esq., President, Public Citizen
--
Member Statements
-
Senator Bernie Sanders (I-VT)
Download File (968.47 KB) -
Senator Richard Burr (R-NC)
Download File (78.01 KB)
Testimony
-
Mr. Robert Weissman, Esq.
PresidentPublic CitizenDownload File (199.36 KB) -
Michael Valentino, R.PhD, MHSA
Chief ConsultantPharmacy Benefits Management ServicesDownload File (47.12 KB) -
Mr. John Rother
President and Chief Executive OfficerNational Coalition on Health CareDownload File (72.02 KB)